M
Marco Barbierato
Publications - 7
Citations - 227
Marco Barbierato is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 119 citations.
Papers
More filters
Journal ArticleDOI
Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve: The FAVOR II Europe‐Japan Study
Jelmer Westra,Birgitte Krogsgaard Andersen,Gianluca Campo,Hitoshi Matsuo,Lukasz Koltowski,Ashkan Eftekhari,Tommy Liu,Luigi Di Serafino,Domenico Di Girolamo,Javier Escaned,Holger Nef,Christoph Naber,Marco Barbierato,Shengxian Tu,Omeed Neghabat,Morten Madsen,Matteo Tebaldi,Toru Tanigaki,Janusz Kochman,Samer Somi,Giovanni Esposito,Giuseppe Mercone,Hernán Mejía-Rentería,Federico Ronco,Hans Erik Bøtker,William Wijns,Evald Høj Christiansen,Niels Ramsing Holm +27 more
TL;DR: Online computation of QFR in the catheterization laboratory is clinically feasible and is superior to angiographic assessment for evaluation of intermediary coronary artery stenosis using FFR as a reference standard.
Journal ArticleDOI
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.
Francesco Gallo,Guglielmo Gallone,Won-Keun Kim,Jörg Reifart,Verena Veulemans,Tobias Zeus,Stefan Toggweiler,Ole De Backer,Lars Søndergaard,Federico De Marco,Damiano Regazzoli,Bernhard Reimers,Guillem Muntané-Carol,Rodrigo Estévez-Loureiro,Ubaldo Álvarez Hernández,Marco Moscarelli,Lorenzo Airale,Fabrizio D'Ascenzo,Xavier Armario,Darren Mylotte,Oliver D. Bhadra,Lenard Conradi,Luis Marroquin Donday,Luis Nombela-Franco,Marco Barbanti,Claudia Reddavid,Enrico Criscione,Salvatore Brugaletta,Elisa Nicolini,Tommaso Piva,Giorgos Tzanis,Federico Ronco,Marco Barbierato,Josep Rodés-Cabau,Antonio Mangieri,Antonio Colombo,Francesco Giannici +36 more
TL;DR: In this article , the authors evaluated outcomes of real-world patients with aortic stenosis undergoing transcatheter aortric valve replacement (TAVR) with the 34 mm Evolut R (Medtronic, Minneapolis, Minnesota).
Journal ArticleDOI
Procedural Outcomes of the 34mm EvolutR Transcatheter Valve in a Real-World Population Insights from the Horse Multicenter Collaborative Registry
Francesco Gallo,Guglielmo Gallone,Won-Keun Kim,Jörg Reifart,Verena Veulemans,Tobias Zeus,Stefan Toggweiler,Ole De Backer,Lars Sondegaard,Federico De Marco,Damiano Regazzoli,Bernahrd Reimers,Guillem Muntané-Carol,Rodrigo Estévez-Loureiro,Ubaldo Álvarez Hernández,Marco Moscarelli,Lorenzo Airale,F. D’Ascenzio,Xavier Armario,Darren Mylotte,Oliver D. Bhadra,Lenrad Conradi,L. A. Marroquin Donday,Luis Nombela-Franco,Marco Barbanti,Claudia Reddavid,Enrico Criscione,Salvatore Brugaletta,Elisa Nicolini,Tommaso Piva,Giorgos Tzanis,Federico Ronco,Marco Barbierato,Josep Rodés-Cabau,Antonio Mangieri,Antonio Colombo,Francesco Giannici +36 more
Journal Article
Balloon-Assisted Crossing of a Severely Calcified Aortic Valve During Transcatheter Balloon-Expandable Bioprosthesis Implantation.
TL;DR: A 91-year-old man presented with syncope secondary to severe aortic stenosis and transfemoral transcatheter AV replacement (TAVR) was the preferred option in view of the patient's age.
Journal ArticleDOI
P202 pretreatment with antagonists of p2y12 platelets receptors in st–elevation myocardial infarction: clinical and angiographic outcomes
Adriana Antonucci,Alessandra Cutolo,F. Gallo,Anna Bellin,Giacomo Cavalli,Marco Barbierato,Sakis Themistoclakis +6 more
TL;DR: Pretreatment in the setting of ACS–STEMI is not associated with benefits in terms of acute or subacute stent thrombosis and perfusion of culprit coronary but may cause clinically relevant bleedings, in particular in the elderly (age > 75).